HMB 7 12 11

download HMB 7 12 11

of 55

Transcript of HMB 7 12 11

  • 7/29/2019 HMB 7 12 11

    1/55

    -Hydroxy--Methylbutyrate(HMB)

    1

  • 7/29/2019 HMB 7 12 11

    2/55

    Educa7onalObjec7vesforthe

    -Hydroxy--Methylbutyrate(HMB)Presenta7on

    ProvideageneraloverviewofHMBintakeandmetabolism Describemechanis;cstudiesoftherolesofHMBincellsignalingpathwaysgoverningbothmuscleproteinsynthesisanddegrada;on DiscussroleofHMBinreducingmuscledamageduringexercise

    Reviewclinicaldataevalua;ngchangesinbodycomposi;onandperformanceinathletesreceivingHMBsupplementa;on

    Usedaloneandincombina;onwithcrea;neorotheraminoacids Includingeffectsinhealthy,olderadults

    Presentothertherapeu;candmedicalapplica;onsAddressthesafetyofHMBsupplementa;on

    2

  • 7/29/2019 HMB 7 12 11

    3/55

    -Hydroxy--Methylbutyrate(HMB)

    3

    Generaloverviewofintakeandmetabolism

  • 7/29/2019 HMB 7 12 11

    4/55

    WhatIsHMB?

    HMBisaleucinemetabolite Leucineisanessen;albranched-chainaminoacidthatcantriggermuscle

    proteinsynthesisandmayinhibitproteindegrada;on1

    Isitunknownwhetherleucineoritsmetabolitesac;velypar;cipateinproteinsynthesis/degrada;on

    Leucineistransaminatedto-ketoisocaproate(KIC)bybranched-chainaminoacidtransferase,mainlyinmuscle;ssues

    Approximately5%to10%of-ketoisocaproate(KIC)isconvertedtoHMB(byKIC-dioxygenase)inthecellcytosol

    CalciumHMBhasthefollowingmolecularstructuralformula2

    1. NemetD,etal.IMAJ.20057:328-332.2. Availableat:www.chemblink.com/products/135236-72-5.htm.AccessedMay10,2011.

    Ca++HO O

    O

    O

    O OH

    4

  • 7/29/2019 HMB 7 12 11

    5/55

    Forma7onofHMBDuringLeucineMetabolism

    AdaptedwithpermissionfromNissenSLandAbumradNN.JNutrBiochem.19978(6):300-311.

    Leucine

    KIC Isovaleryl-CoA

    -methyl-crotonyl-CoA(MC-CoA)

    -hydroxy--methylbutyrate

    (HMB)

    HMB-CoA

    HMG-CoA

    Mevalonate

    Acetyl-CoACholesterol

    (5-10% of

    Leu metabolism)

    Acetoacetyl-CoA

    (only when

    biotin is deficient)

    5

  • 7/29/2019 HMB 7 12 11

    6/55

    SourcesofHMBintheDiet

    Catabolismofleucine Meanintakeofleucinefromfoodandsupplements(1988-1994NHANESIII)was6.1g/day1

    Assuming5%to10%conversioninthebody,thisrepresents0.3to0.6gHMBperday

    Togetthe3-gHMBdosetypicallyusedinresearch,30-60gleucine/daywouldhavetobeconsumed

    HMBinfoods TherearetracesofHMBinmanyanimal-andplant-basedfoods,especially

    ca_ishandalfalfa2

    1. Ins;tuteofMedicineoftheNa;onalAcademies.DietaryReferenceIntakesforEnergy,Carbohydrate,Fiber,Fat,FayAcids,Cholesterol,Protein,andAminoAcids.Washington,DC:TheNa;onalAcademiesPress2005:1008.

    2. Availableat:hp://www.webmd.com/heart-disease/news/20000818/researchers-take-closer-look-at-supplement-sensa;on.AccessedMay10,2011. 6

  • 7/29/2019 HMB 7 12 11

    7/55

    HMBAbsorp7onandKine7cs

    ThemechanismofHMBabsorp;onfromtheintes;nehasnotbeenreported

    In2kine;ctrials,plasmahalf-lifewas2.5hours HMBlevelsreturntobaselineat~9hoursaeringes;on Upto30%ofanoralHMBdoseisexcretedunchangedintheurine

    Theaddi;onofglucosetoacalciumHMBsupplementdoesnotincreasebioavailabilityorcellularuptakeofHMB AddedglucosedoesslowHMBabsorp;onthroughdelayedgastric

    emptying

    VukovichMD,etal.JNutrBiochem.200112(11):631-639.7

  • 7/29/2019 HMB 7 12 11

    8/55

    HMBBioavailability

    ReprintedfromFullerJCJr,etal.BrJNutr.2011105:367-372.

    BioavailabilityofafreeacidgelformwasgreatervscalciumHMBcapsules 2studies,eachwith8healthyadults(4male,4female) 3treatments 1gcalciumHMBincapsuleform

    EquivalentamountofHMBinfreeacidforminagel(swallowedimmediately) FreeacidHMBgelheldsublinguallyfor15sec,thenswallowed

    BloodandurinaryHMBlevelsweremonitoredfor3to24hoursaeringes;on Onlycommerciallyavailableformiscalciumsalt

    aP

  • 7/29/2019 HMB 7 12 11

    9/55

    -Hydroxy--Methylbutyrate(HMB)

    9

    Mechanismsofac7on

  • 7/29/2019 HMB 7 12 11

    10/55

    PossibleHMBMechanismsofAc7on

    HMBmaybeanan;catabolicagent Studieshavedocumentedpoten;allyinhibitedpathwayssuchasthe

    ubiqui;n-proteasomepathwayinamurinemodel1,2

    HMBmaybeasubstrateforcholesterolsynthesisinmuscle3 Forma;onof3-hydroxy-3-methylglutarylCoenzymeA(HMG-CoA,precursor

    forcholesterolsynthesis)

    Muscleisdependentoncholesterolsynthesistomeetitsneeds Increasedcellmembraneintegritywithimprovedmusclecholesterol

    synthesis

    StressedorinjuredmusclecellsmightnotsynthesizeenoughcholesterolHMBalsohelpstos;mulateproteinsynthesisviathemTORpathway4

    Maybetherealfactorbywhichleucines;mulatesproteinsynthesisHMBmayhaveothereffects(eg,immunomodulatoryorhormonal)5

    1. LeckerSH,etal.JNutr.1999129:227S-237S.2. SmithHJ,etal.CancerRes.200565:277-283.3. NissenSLandAbumradNN.JNutrBiochem.19978:300-311.4. EleyHL,etal.AmJPhysiolEndocrinolMetab.2008295:E1409-E1416.5. ZanchiNE,etal.AminoAcids.201140(4):1015-1025.

    10

  • 7/29/2019 HMB 7 12 11

    11/55

    TheUbiqui7n-ProteasomePathwayforProtein

    Degrada7on

    ReprintedfromLeckerSH,etal.JNutr.1999129:227S-237S.11

  • 7/29/2019 HMB 7 12 11

    12/55

    EffectsofHMBontheUbiqui7n-ProteasomePathway

    ReprintedfromSmithHJ,etal.CancerRes.200565:277-283.

    aP

  • 7/29/2019 HMB 7 12 11

    13/55

    EffectsofHMBonProteinSynthesisandDegrada7on

    Initiator (PIF, LPS, TNF- , angiotensin II, etc.)

    Caspase-8

    Caspase-3

    PKR

    p38 MAPKPKR P

    eIF2 eIF2 P

    Translational efficiency

    Protein synthesis

    ROSNF- (nuclear accumulation)

    Proteasome + E3 mRNA

    Protein degradation

    HMB blocks pathway

    here

    X

    PIF,proteolysis-inducingfactorLPS,lipopolysaccharideTNF,tumornecrosisfactorPKR,RNA-dependentproteinkinaseMAPK,mitrogen-ac;vatedprotein

    kinaseNF,nuclearfactorROS,reac;veoxygenspecieseIF,eukaryo;cini;a;onfactorP,phosphorylated.

    BasedonEleyHL,etal.AmJPhysiolEndocrinolMetab.2008295:E1417-E1426.

    13

  • 7/29/2019 HMB 7 12 11

    14/55

    FurtherEffectsofHMBonCellularProteinSynthesis

    HMBincreasesmTORsignalingpathwayac;vity

    mTORincreasesprotein

    transla;on

    Promotesit Keepsitfrombeingturnedoff

    EleyHL,etal.AmJPhysiolEndocrinolMetab.2008295:E1409-E1416.

    AdaptedfromSABiosciences,aQIAGENcompany.Availableat:hp://www.sabiosciences.com/pathway.php?sn=mTORPathway.AccessedJune27,2011.14

  • 7/29/2019 HMB 7 12 11

    15/55

    0.90.80.7

    0.60.50.4

    0-2D

    ensitometryunits,

    ph/tot

    a

    0.30.20.1

    -1 0 2Time, h

    p mTOR

    Total mTOR

    1.6

    1.41.21.00.8

    0-2

    Densitometryunits,p

    h/tot

    b

    0.60.40.2

    -1 0 2Time, h

    p P70S6K

    Total P70S6K

    EffectsofHMBonPhosphoryla7onStatusofmTOR

    PathwaySignalingFactors

    ReprintedfromEleyHL,etal.AmJPhysiolEndocrinolMetab.2007293:E923-E931.

    HMB (50 M) added here to murine myotubes.

    HMBincreasedphosphoryla;onofmTORsignalingfactors,s;mula;ngproteinsynthesis

    HMBaenuatesthedepressiveeffectsofproteolysis-inducingfactoronproteinsynthesis

    aDifferentfromcontrol,P

  • 7/29/2019 HMB 7 12 11

    16/55

    -Hydroxy--Methylbutyrate(HMB)

    16

    HMBandindicatorsofmuscledamage

  • 7/29/2019 HMB 7 12 11

    17/55

    EvidenceforaProtec7veEffectofHMBAgainstMuscle

    CellMembraneDisrup7on

    Exercisecanresultinmusclecellmembranedisrup;on1,2Eleva;onsofcrea;nekinase(CK)andotherenzyme(eg,lactatedehydrogenase[LDH])levelsinthebloodcanbeindicatorsofmusclecellmembranedisrup;on3,4

    NotnecessarilymuscleproteinbreakdownAfewexercisestudieshavefoundabluntedCKresponseduringHMBsupplementa;on5,6

    1. McBrideJM,etal.MedSciSportsExerc.199830(1):67-72.2. HurleyBF,etal.IntJSportsMed.199516(6):378-384.3. CabanissCD.In:WalkerHK,HallWD,HurstJW,eds.ClinicalMethods:TheHistory,Physical,and

    LaboratoryExaminaKons.3rdedi;on.Boston:Buerworths1990:Chapter32.

    4. SarriE,etal.BiochemJ.2006394(pt1):325-334.5. KnierAE,etal.JApplPhysiol.200089:1340-1344.6. vanSomerenKA,etal.IntJSportNutrExercMetab.200515(4):413-424.

    17

  • 7/29/2019 HMB 7 12 11

    18/55

    EffectofHMBSupplementa7ononCrea7neKinaseLevels

    DuringExercise

    KnierAE,etal.JApplPhysiol.200089:1340-1344.

    Studyinvolving13par;cipants(5male,8female)thathadahistoryofrunningatleast48km/wk

    Par;cipantsreceived3gHMBorplacebodailyfor6weeksbeforeaprolongedrun(double-blind)

    Pair-matchedbasedonbest2-milerun;me Therunwas20kmonacollegiatecross-countrycourse

    CKandLDHweremeasured2weeksbeforetherun(Pre),immediatelyaertherun(Post),andat1,2,3,and4daysaertherun

    Results follow on next slide

    18

    ff f

  • 7/29/2019 HMB 7 12 11

    19/55

    EffectofHMBSupplementa7ononCrea7neKinaseLevels

    DuringExercise(Contd)

    ReprintedfromKnierAE,etal.JApplPhysiol.200089:1340-1344.

    MaineffectfortreatmentinCKmeasurement, P=.05,withnosignificantgroup;meinterac;on

    AsignificantmaineffectfortreatmentinLDHmeasurement( P=.003),withnosignificantgroup;meinterac;on

    450

    400

    350

    300

    250

    0Pre

    CPKactivity,U/L

    200

    150

    100

    1dPost

    3dPost

    Post 2dPost

    4dPost

    Time relative to the prolonged run

    50

    Placebo

    HMB

    19

    ff f l 7 l

  • 7/29/2019 HMB 7 12 11

    20/55

    EffectsofHMBSupplementa7ononMuscleDamage

    DuringExercise

    1studyshowedposi;veeffectsof3gHMBand0.3gKIC/dayversusplacebowhenreceivedfor2weekspriortoexercise(bicepscurlwithprolongedeccentricphase) 1

    In6nonresistance-trainedmalesubjects Supplementa;onreducedthedelayedonsetofmusclesoreness(DOMS)ra;ngs

    (P

  • 7/29/2019 HMB 7 12 11

    21/55

    -Hydroxy--Methylbutyrate(HMB)

    21

    EffectsofHMBonbodycomposi7onandstrength

  • 7/29/2019 HMB 7 12 11

    22/55

    HistoricalBackgroundonHMBSupplementa7on

    NumerousstudiesofHMBsupplementa;oninseveralanimalmodels(steers,lambs,rats,chickens,trout,andhorses)showedposi;veeffects

    on

    Carcassquality,proteinmetabolism,immuneresponse,muscledamage,an;oxidantstatus,andbloodlipidprofile

    Dr.SteveNissen(AnimalScience,IowaStateUniversity)isessen;allythefatheroftheHMBstory

    Performedini;alhumanstudiesofHMBsupplementa;oninthe1990s 1 Alsoperformedameta-analysisofsupplementa;onstudiesin2003with

    respecttoeffectsonleanbodymassandstrengthgains 2

    1. NissenS,etal.JApplPhysiol.199681(5):2095-2104.2. NissenSLandSharpRL.JApplPhysiol.200394:651-659.

    22

    Ch i O ll M l St th D i HMB

  • 7/29/2019 HMB 7 12 11

    23/55

    ChangeinOverallMuscleStrengthDuringHMB

    Supplementa7on:Ini7alStudy

    ReprintedfromNissenS,etal.JApplPhysiol.199681(5):2095-2104.

    aP

  • 7/29/2019 HMB 7 12 11

    24/55

    ChangeinUrinary3-Methylhis7dine(3-MH)Excre7on

    DuringHMBSupplementa7on:Ini7alStudy

    ReprintedfromNissenS,etal.JApplPhysiol.199681(5):2095-2104.EliaM,etal.BrMedJ.1981282:351-354.

    3-MHisamuscle-specificaminoacid Formedduringbreakdownofmuscleproteins(ac;nandmyosin) Excretedunchangedinurine

    HMBsupplementa;onreducedthephysiologicincreasein3-MHduringexercise

    aP

  • 7/29/2019 HMB 7 12 11

    25/55

    ChangeinFat-FreeMassDuringHMBSupplementa7on:

    Study2

    Totalbodyelectricalconduc;vity(TOBEC)wasusedforbody

    composi;onanalysis

    HMBsupplementa;onincreasedfat-freemassearlyinexercise

    regimencomparedwithplacebo

    Significantgainscon;nuedthroughday39

    ReprintedfromNissenS,etal.JApplPhysiol.199681(5):2095-2104.

    32healthyadults(19-22yearsmeanbodyweight,99kg),almostallengagedinanexerciseprogrambeforestudyentryandateatuniversitytrainingtable

    Randomizedtoplaceboor3gHMBperdayfor7weeks HMBprovidedinanutrient/proteinpowderplacebowasisocaloricorangejuice

    Par;cipantsatenormaldiet(nostrictdietarycontrol) Dailyproteinintakewases;matedat200g(HMB)vs180g(placebo)

    Par;cipantsliedweights2to3hours/day,6days/week

    aP

  • 7/29/2019 HMB 7 12 11

    26/55

    Posi7veEffectsofHMBSupplementa7ononStrength,

    Power,and/orBodyComposi7on

    26

    StudyDesign Treatment Training Results

    Double-blindin

    untrainedcollege

    men,N=371

    0,38,or76mg/kg/

    dayHMB(equivalent

    to0,3,or6g/day)for8wks

    Resistance,

    3;mes/wk(80%1-

    RM)assessedevery2wks

    Comparedwithother2groups,Fat-freemassincreasedinthe38mg/kgdosegroup(P

  • 7/29/2019 HMB 7 12 11

    27/55

    StudiesShowingNoEffectsofHMBSupplementa7onon

    StrengthandBodyComposi7on

    27

    StudyDesign Treatment Training Results

    Randomized,double-

    blindinexperienced

    (5.5years),

    resistance-trained

    athletes,N=401

    0,3,or6g/dayHMB

    for28daysina

    carbohydrate/protein

    powder

    Maintained

    individualized

    resistancetraining

    program(~7hrs/wk)

    andkepttraining

    logs

    NeitherdoseofHMBinfluencedStrength(1-RM)Bodycomposi;on(bydualenergyX-rayabsorp;ometer)Bodyanabolic/catabolicstatusBloodchemistries

    Randomized,double-

    blindinna;onal-level

    athletes(polo,17

    rowers,10)with2yearsofresistance

    training,N=272

    3g/dayHMB(;med-

    releaseorstandard

    capsule)orplacebo

    for6wks

    Resistance,

    2-3;mes/wk

    (Pre-compe;;on

    phaseoftraining)

    NeitherdoseofHMBinfluencedStrengthBodycomposi;onCrea;nekinaselevels Trendtowardhighercrea;nekinaselevelinplacebogroup(P=.07forgroupx;meinterac;on)

    Randomized,

    crossoverin

    collegiatefootball

    players,N=353

    3g/dayHMBor

    placebofor4wks

    (16playersgotHMB

    first,19gotplacebo

    first)

    Intensiveresistance,

    20hrs/wkand

    variousothertypes

    Nochangesinbodycomposi;onorstrengthforeitherplaceboorHMBgroupsLackofchangeinplacebogroupsuggestsovertraining

    Randomized,single-

    blindincollegiate

    footballplayers,

    N=264

    3g/dayHMBor

    placebofor10days

    Preseasontraining

    campNochangesbetweenbaselineandposttrainingineitherplaceboorHMBgroupsforanaerobicpower

    NochangesbetweenplaceboandHMBgroupsforchangesincrea;nekinase,myoglobin,

    testosterone,orcor;sollevels

    Abbrevia;ons:RM,repe;;onmaximum.1.KreiderRB,etal.IntJSportsMed.199920(8):503-509.2.SlaterG,etal.IntJSportNutrExercMetab.200111(3):384-396.3.RansoneJ,etal.JStrengthCondRes.200317(1):34-39.4.HoffmanJR,etal.JStrengthCondRes.200418(4):747-752.

  • 7/29/2019 HMB 7 12 11

    28/55

    WhytheDiscrepancyinHMBStudies?

    Therearepoten;aldifferencesinmusclemetabolismbetweenmorehighlytrainedanduntrainedathletes

    Morepoten;alforbenefitprobablyinuntrainedathletesLengthofHMBsupplementa;onmayhavebeeninsufficientinnega;vestudies

    Morehighlytrainedathletesmightrequirelongersupplementa;on(only1nega;vestudy>4weeksdura;on)

    Verylimiteddata(only2studies)onHMBdosesover3g/day Largerbodysizemightrequirealargerdose

    TypeoftrainingmaybeimportantDifferencesbetweenlaboratoriesThereareseveralgoodmeta-analysesandreviewsofHMBandathle;cperformance1-6

    1. PortalS,etal.JPedEndocrinolMetab.201023(7):641-650.2. ZanchiNE,etal.AminoAcids.201140(4):1015-1025.3. AlonT,etal.ResCommMolPatholPharmacol.2002111(1-4):139-151.4. NissenSLandSharpRL.JApplPhysiol.200394:651-659.5. RowlandsDSandThomsonJS.JStrengthCondRes.200923(3):836-846.6. WilsonGJ,etal.NutrMetab.20085:1DOI:10.1186/1743-7075-5-1.

    28

  • 7/29/2019 HMB 7 12 11

    29/55

    CounterfeitHMB?

    Theini;alhumanresearchonHMBcamefromSteveNissenslaboratoryatIowaState

    Thecompoundtheystudiedandtheoneintheirassociatedpatentscalcium-hydroxy--methylbutyrate

    AproductmarketedintheUK(HMB-1000,MaximuscleLtd.)hasbeenshowninonestudytobeineffec;veatreducingexercise-

    inducedmuscledamage1SubsequentanalysisoftheHMB-1000productrevealedthatitactuallycontainednoHMB2

    Itcontainsarelatedleucinemetabolite(calciumhydroxy-methylbutyrate)Thisraisesthepoten;alissuethatsomenoeffectstudieswithHMBcouldbeduetouseofaproductthatdoesnotcontainHMB,butrathersimilarcompoundsthatmightnothavethesamebiologicalac;vity

    1Nunan et al. J Strength Cond Res 2010;24:531-537.2Abumrad NN, Rathmacher JA. J Strength Cond Res 2011:25(7):1-2.

  • 7/29/2019 HMB 7 12 11

    30/55

    -Hydroxy--Methylbutyrate(HMB)

    30

    HMBandaerobicperformance

  • 7/29/2019 HMB 7 12 11

    31/55

    HMBandMeasuresofAerobicCapacity

    MostoftheresearchregardingHMBhasfocusedonstrengthandbodycomposi;on

    AbilitytotrainharderwithlessmusclebreakdownfromexercisemaybeamechanismthroughwhichHMBcouldfacilitateaerobicperformance

    2studieshaveevaluatedaerobiccapacityduringHMBsupplementa;on1,2 Inthesestudies,themechanismofhowHMBmightworkisnotclear

    1. VukovichMDandDreifortGD.JStrengthCondRes.200115(4):491-497.2. LamboleyCR,etal.IntJSportNutrExercMetab.200717(1):56-69.

    31

  • 7/29/2019 HMB 7 12 11

    32/55

    MeasuresofAerobicCapacity:Study1

    Randomized,double-blind,crossoverstudyinvolving8endurance-trainedcyclists

    Received3g/dayHMB,leucine,orplaceboforthree2-weeksupplementa;onperiods,with2-weekwashoutperiodsinbetween

    Par;cipantsperformedgradedcycleergometrytests VO2peak,VO2max,andlactateaccumula;onpeakweresimilarbetweenall

    groups

    Onsetofbloodlactateaccumula;on(VO2atbloodlactatelevelof2mM)wasincreasedinboththeHMBandleucinegroupscomparedwiththeplacebogroup(9.1%,2.1%,and0.8%,respec;vely)

    Leucinehadnoothernotableeffectsonaerobicparameters Lactatethreshold(%VO2max),and;metoreachVO2peakwerealso

    increasedintheHMBgroupcomparedwiththeleucineandplacebogroups

    BloodHMBlevelsweremuchlower(40-to60-fold)intheleucinegroupversustheHMBgroup

    SupportspreviousdataonlowconversionratesofleucinetoHMBVukovichMDandDreifortGD.JStrengthCondRes.200115(4):491-497.

    32

  • 7/29/2019 HMB 7 12 11

    33/55

    MeasuresofAerobicCapacity:Study2

    Randomizedstudyinvolving16collegestudents

    Received3g/dayHMBorplacebofor5weeks

    Studentsperformedintervaltraining3;mes/weekonatreadmill Comparedwiththeplacebogroupat5weeks,theHMBgrouphad

    IncreasedVO2max(13.4%vs8.4%forplaceboP

  • 7/29/2019 HMB 7 12 11

    34/55

    -Hydroxy--Methylbutyrate(HMB)

    34

    HMBstudieswithcrea7neorwithaminoacids

  • 7/29/2019 HMB 7 12 11

    35/55

    HMBinCombina7onWithCrea7ne

    Anaturalques;oniswhethersynergis;coraddi;veeffectswilloccurduringsimultaneoussupplementa;onwithcrea;neandHMB

    Clinicaldatahavereportedmixedresults Randomized,double-blindstudyinvolving40volunteers

    Received3g/dayHMB,20g/dayfor7daysfollowedby10g/dayfor14dayscrea;ne(Cr),crea;neplusHMB(CrHMB),orplacebofor3weeks

    Volunteersperformedprogressiveresistancetraining Leanbodymassgains(assessedviabioelectricimpedance)were0.92kg,0.39kg,and1.54kggreaterforCr,HMB,andCrHMBgroups,respec;velycomparedwithplacebo

    SignificantmaineffectforCrgroup(P=.05),andatrendforHMBgroup(P=.08) Datawereaddi;ve,noCrHMBinterac;on(P=.73)

    Similarresultswerereportedforstrengthgains,withaddi;veeffectsforCrandHMB Reduc;oninexercise-inducedcrea;nephosphokinaselevelswasgreatestinthe

    HMBgroup(maineffect,P=.01) Addi;onofcrea;neantagonizedtheHMBeffect( P=.04forCrHMBinterac;on)

    JwkoE,etal.NutriKon.200117(7-8):558-566.35

  • 7/29/2019 HMB 7 12 11

    36/55

    HMBinCombina7onWithCrea7ne

    Randomizedstudyinbasketballplayers1 Receivedcrea;ne,HMB,crea;neandHMB,orplacebofor30days

    Doseswerenotspecified Playersinthecombina;ongrouphadincreasedmaximumpowerandtotal

    workoutputcomparedwiththeothergroups

    Noaddi;onalincreaseinlactateorfallinmusclepH2studiesdidnotshowbenefitsofthecrea;ne/HMBcombina;on

    2,3

    Bothstudieswerein57eliterugbyplayers(N=30N=27) Received3g/dayHMB,3g/daycrea;ne,crea;neandHMB,orplacebofor6

    weeks

    NobenefitswereobservedonMuscularstrengthandendurance

    Legpower Anthropometry Aerobicability Anaerobicability

    1. ZajacA,etal.JHuminet.200310:95-108.2. OConnorDMandCroweMJ.JStrengthCondRes.200721(2):419-423.3. OConnorDMandCroweMJ.JSportsMedPhysFitness.200343(1):64-68.

    36

    HMB in Combina7on With the Amino Acids Arginine

  • 7/29/2019 HMB 7 12 11

    37/55

    HMBinCombina7onWiththeAminoAcidsArginine,

    Glutamine,andTaurine

    Randomized,double-blindstudyinvolving17healthymenwhowererecrea;onallyac;ve(noresistancetraininginprevious6months)

    ReceivedHMBplusaminoacids(MA)oranisonitrogenouscontroltwicedailyfor12weeks

    MAformula=1.5gHMB,7gglutamine,7garginine,3gtaurine,5.8gdextrose Control=10gglycine,11.5galanine,1.5gglutamate,1.5gserine

    Volunteersperformedresistancetraining3;mes/week(10exercisesforwholebody) Onelight(12-to14-repe;;onmaximum[RM]),1moderate(8-to10-RM),and

    1heavy(3-to5-RM)dayeachweek

    Outcomevariables Strength(1-RM) Ver;caljumppower Hormonalandmuscledamageresponsestoanacuteboutofresistance

    training

    Bodycomposi;onandcircumferences Tendonsize

    ResultsfollowonnextslidesKraemerWJ,etal.MedSciSportsExerc.200941(5):1111-1121.

    37

    Body Composi7on Changes During Supplementa7on

  • 7/29/2019 HMB 7 12 11

    38/55

    BodyComposi7onChangesDuringSupplementa7on

    WithHMBandAminoAcids

    aSignificantdifferencefromV1,P.05bSignificantdifferencefromcontrol,P.05

    Abbrevia;ons:V1,beforetrainingV5,aer6wksV8,aer12wks.

    KraemerWJ,etal.MedSciSportsExerc.200941(5):1111-1121.

    Bodymassandleanbodymasscon;nuouslyincreasedinbothgroups Bodyfatcon;nuouslydecreasedinbothgroups Aer12weeksoftraining,thesupplementa;ongrouphadsignificantlyimprovedbodycomposi;on

    a

    95

    90

    85

    80

    75

    70V1 V5 V8

    Time point

    Bodymass,kg

    a,b

    CON

    MA

    A

    a

    80

    75

    65

    60

    55

    50V1 V5 V8

    Time point

    Leanbodymass,kg

    a,b

    B

    a

    32

    30

    26

    22

    1816

    V1 V5 V8Time point

    Bodyfat,%

    a,b

    C

    28

    24

    20

    70

    CON

    MA

    CON

    MA

    38

    Strength and Power Changes During Supplementa7on

  • 7/29/2019 HMB 7 12 11

    39/55

    StrengthandPowerChangesDuringSupplementa7on

    WithHMBandAminoAcids

    aSignificantdifferencefromV1,P.05bSignificantdifferencefromcontrol,P.05

    Abbrevia;ons:V1,beforetrainingV5,aer6wksV8,aer12wks.

    KraemerWJ,etal.MedSciSportsExerc.200941(5):1111-1121.

    Bothmusclestrengthandpowercon;nuouslyincreasedinbothgroups Aer6weeksoftraining,thesupplementa;ongrouphadsignificantlyimprovedmusclestrengththatremainedenhancedatthe12-weekassessment

    At12weeks,thesupplementa;ongrouphadsignificantlyimprovedmusclepower

    140

    120

    100

    80V1 V5 V8

    Time point

    Squat,kg

    A

    120

    80

    60

    V1 V5 V8Time point

    Bench,kg

    B

    6000

    5000

    4500

    3500

    3000V1 V5 V8

    Time point

    Verticaljumppower,w

    C

    5500

    4000

    100

    a

    a,b

    a,b

    a

    a,b

    a

    CON

    MAa,b

    a

    a,b CON

    MA

    CON

    MA

    39

    Changes in Hormone Levels and Indicators of Muscle Damage

  • 7/29/2019 HMB 7 12 11

    40/55

    ChangesinHormoneLevelsandIndicatorsofMuscleDamage

    DuringSupplementa7onWithHMBandAminoAcids

    Comparedwiththeplacebogroup,thesupplementa;ongrouphad Increasedres;ngandexercise-inducedtestosteronelevels Increaseres;nggrowthhormoneconcentra;ons Reducedpre-exercisecor;solconcentra;ons Aenuatedcircula;ngcrea;nekinaseandmalondialdehydeconcentra;ons

    Indica;veoflessmuscledamage Ingeneral,theeffectsfromsupplementa;ononcrea;nekinase,malondialdehyde,andcor;solweremorepronouncedatthe12-week

    pointinthestudy

    Nodietaryintakedatawerereportedforthestudy

    KraemerWJ,etal.MedSciSportsExerc.200941(5):1111-1121.40

  • 7/29/2019 HMB 7 12 11

    41/55

    -Hydroxy--Methylbutyrate(HMB)

    41

    HMBintheelderly

    andtherapeu7c/medicalapplica7ons

  • 7/29/2019 HMB 7 12 11

    42/55

    HMBintheElderly

    Thereareanumberofnutri;onalproblemsintheelderlypopula;onforwhichtheremaybeapplica;onsforHMB

    Sarcopeniaduetoagingandinac;vity1 Bedrest Inabilitytoperformexercisethatcanhelpmaintainmusclemass

    Woundhealing(eg,decubi;)2 Presenceofdiseasestates(eg,cancer,conges;veheartfailure)associated

    withsignificantcachexia3,4

    Generalizedmalnutri;on5HMBhasbeenstudiedinbothhealthyelderlyandthosewithvariouscondi;onsassociatedwithlossofmusclemassandwoundhealingcapacity

    1. BaierS,etal.JPENJParenterEnteralNutr200933(1):71-82.2. WilliamsJZ,etal.AnnSurg.2002236(3):369-375.3. HsiehLC,etal.AsiaPacJClinNutr.200615(4):544-550.4. MayPE,etal.AmJSurg.2002183(4):471-479.5. HsiehLC,etal.AsiaPacJClinNutr.201019(2):200-208.

    42

    BodyComposi7onandProteinMetabolisminHealthy

  • 7/29/2019 HMB 7 12 11

    43/55

    ody Composi7on and Protein Metabolism in Healthy

    OlderAdultsDuringHMBSupplementa7on

    3studieshaveevaluatedHMBinrela;velyhealthyelderlyadults(>70years) Randomized,double-blindstudyinvolving31adults(men,15women,16)

    70yearsofage1

    Received3g/dayHMBorplacebofor8weeks Par;cipantsunderwentanexerciseprogram5day/week

    2randomized,double-blindstudiesinvolving127elderlyadults(N=50,allwomenN=77,men38andwomen39) 2,3

    Received2to3gHMB+1.5to2.25glysine+5to7.5garginineperdayorisocaloric,isonitrogenousplacebo

    Studydura;onswere12weeks2and1year3 Noexercisecomponent

    Generalfindingsfromthesestudies Someimprovementsinbodycomposi;on(leanmass,fatmass) Increasedproteinturnover Improvementinselectedmeasuresofstrengthandfunc;onaltests

    ImprovementsdidnotalwaysoccurineitherplaceboorHMBgroup Indicatesthatthepar;cipantsmightnothavebeenabletodotheexercises

    adequately

    Benefitswerestrongerduringtheearlierperiodofthestudiesandtaperedtowardthestudyend

    1. VukovichMD,etal.JNutr.2001131:2049-2052.2. FlakollP,etal.NutriKon.200420(5):445-451.3. BaierS,etal.JPENJParenterEnteralNutr.200933(1):71-82.

    43

  • 7/29/2019 HMB 7 12 11

    44/55

    HMBandWoundHealing

    EffectsofHMBonbodycomposi;onandproteinturnoverledtoinves;ga;onsofHMBeffectsoncollagensynthesisandwoundhealing

    Randomizedstudyinvolving35healthyadults(men,8women,27meanage,75years)

    Crea;onofsmallwoundswithplas;ctubularinsertsthatwereplacedinthedeltoid Received14garginine+3gHMB+14gglutamineperday(n=18)oranisocaloric,

    isonitrogenouscontrol(n=17)for2weeks

    At2weeksposreatment Hydroxyprolineconcentra;on(surrogateforcollagenproduc;on)wasincreasedintheHMBgroupcomparedwiththecontrolgroup(72.2nmol/cmimplantvs43.2

    nmol/cmimplantP

  • 7/29/2019 HMB 7 12 11

    45/55

    p

    HIV-InfectedPa7ents

    Randomized,double-blindstudyinvolving43pa;entsinfectedwithHIVwhohaduninten;onalweightloss>5%overthe

    previous3months

    Received3gHMB+14gglutamine+14garginineperdayorplacebo(maltodextrin,isocaloric)for8weeks

    WouldhavebeenbeertoalsohaveisonitrogenousplaceboOutcomevariables

    Bodycomposi;onbyairdisplacementplethysmographyandskinfolds T-cellsubsets Changeinviralload

    Resultsfollowonnextslide

    ClarkRH,etal.JPENJParenterEnteralNutr.200024(3):133-139.45

    OutcomesDuringSupplementa7onWithHMBand

  • 7/29/2019 HMB 7 12 11

    46/55

    g pp

    AminoAcidsinHIV-InfectedPa7ents

    Bodycomposi;onimprovedinthesupplementa;ongroupcomparedwiththeplacebogroup Differencesweresignificantwithin8weeks

    T-cellsubsets(CD3andCD5)werealsoincreasedsignificantlyinthesupplementa;ongroupcomparedwiththeplacebogroup

    ViralloaddecreasedsignificantlywithHMB/Arg/Glutsupplementa;oncomparedwithplacebo

    ReprintedwithpermissionfromClarkRH,etal.JPENJParenterEnteralNutr.200024(3):133-139.

    aP=.009bP=.003

    Placebo

    HMB/Arg/Gln

    5

    4

    -1

    Cum

    ulativeweightgain,kg

    3

    2

    1

    Start

    0

    4 weeks 8 weeks

    a

    PlaceboHMB/Arg/Gln

    -1Cum

    ulativeleangain,kg

    3

    2

    1

    Start

    0

    4 weeks 8 weeks

    b

    46

    OtherPosi7veHMBStudiesinCachec7c-Prone

  • 7/29/2019 HMB 7 12 11

    47/55

    Popula7ons

    Studieswith3gHMB+14gglutamine14garginineperday Randomized,double-blindstudyinvolving32pa;entswithsolidtumors

    whohaduninten;onalweightloss>5%1

    ReceivedHMB/arginine/glutamine,orisonitrogenous,isocaloricplacebofor24weeks

    By4weeks,gainsinbodyweightandfat-freemasswereobservedinthesupplementa;ongroupcomparedwiththeplacebogroup

    At23weeks,posi;veeffectsfromthesupplementa;onweremaintained Randomized,blindedstudyinvolving100cri;callyilltraumapa;ents2

    ReceivedHMG,HMB/arginine/glutamine,orisonitrogenous,isocaloricplacebofor28days

    Aer7daysofsupplementa;on Nitrogenreten;onwassignificantlyimprovedinthesupplementedgroupscompared

    withtheplacebogroup(P=.05)

    Urinary3-methylhis;dine(indicatorofmuscleproteolysis)wasunaffectedbysupplementa;on

    1.MayPE,etal.AmJSurg.2002183(4):471-479.2. KuhlsDA,etal.JTrauma.200762(1):125-132.

    47

    OtherPosi7veHMBStudiesinCachec7c-Prone

  • 7/29/2019 HMB 7 12 11

    48/55

    Popula7ons

    StudieswithHMBalone1,2 In34pa;entswithchronicobstruc;vepulmonarydiseasewhowererandomizedto

    3g/dayHMBorcontrolfor7days,HMB-treatedpa;entshadimprovedindicatorsforinflamma;onandproteinbalancecomparedwiththecontrolgroup

    In79bed-riddenelderlyadultswhowererandomizedto2g/dayHMBorcontrolfor14days,HMB-treatedadultshadreducedmuscleproteinbreakdowncomparedwith

    thecontrolgroup

    1.HsiehLC,etal.

    AsiaPacJClinNutr.200615(4):544-550.2. HsiehLC,etal.AsiaPacJClinNutr.201019(2):200-208.

    48

    StudiesShowingNoEffectsofHMB/Arginine/Glutamine

  • 7/29/2019 HMB 7 12 11

    49/55

    g g

    Supplementa7on

    Randomizedstudyinvolving40pa;entswithrheumatoidcachexia1 ReceivedHMB/arginine/glutamineorisocaloric,isonitrogenousplacebofor

    12weeks

    Similarimprovementsinbodycomposi;onandphysicalfunc;onwerereportedinbothgroups

    Pa;entsreceivingsupplementa;onwerelesscachec;cvsotherstudies However,theMayPE,etal.studyhadhighdropoutrateduetoverysickpopula;on

    Randomizedstudyinvolving30pa;entsundergoinglaparoscopicgastricbypasssurgery2 Received24gHMB/arginine/glutaminetwicedailyornosupplementa;on

    post-opera;velyfor8weeks

    Nodifferencesbetweengroupsinchangesofbodyweight,composi;on,orres;ngmetabolicrate

    Noadverseeffectsonweightloss

    1. MarcoraS,etal.ClinNutr.200524(3):442-454.2. ClementsRH,etal.SurgEndosc.201025(5):1376-1382.49

  • 7/29/2019 HMB 7 12 11

    50/55

    -Hydroxy--Methylbutyrate(HMB)

    50

    HMB:Safety

  • 7/29/2019 HMB 7 12 11

    51/55

    SafetyProfileofHMB:AnimalStudies

    Variousanimalstudies(laboratoryandlivestockanimals)haveshownnoadverseeffectsevenathighdoses(upto4g/kg)1and

    someposi;veeffects

    Decreasedmortality(probablyduetoenhancedimmunity)2,3 Decreasedmuscleproteinbreakdown4 Improvedcarcassquality(morelean,lessfat)5

    A90-daytoxicologystudyinratswithHMBat5%ofdiet(3.49g/kgformales,4.16g/kgforfemales)showedthatthisdosehadno

    observedadverseeffects6

    Thisincludedchangesinfoodconsump;onandbodyweight,aswellasclinicalchemistries,organweights,hematology,andmacro-andmicroscopic;ssueexamina;ons

    1. PapetI,etal.BrJNutr.199777(6):885-896.2. NissenS,etal.PoultSci.199473(1):137-155.3. PetersonAL,etal.ImmunopharmImmunotox.199921(2):307-330.4. HolecekM,etal.FoodChemToxicol.200947(1):255-259.5.

    VanKoeveringMT,etal.JAnimSci.199472(8):1927-1935.6. BaxterJH,etal.FoodChemToxicol.200543(12):1731-1741.

    51

  • 7/29/2019 HMB 7 12 11

    52/55

    SafetyProfileofHMB:HumanStudies

    HMBhasbeenmarketedextensivelyasadietarysupplementsince1996withnopaernofadverseeventreports

    Clinicalstudiesevalua;ngHMBorHMB+crea;nesupplementa;onforperiodsof3to8weekswithdosesupto6g/dayHMBhaveshown1-3 Noadversehematological,hepa;c,orrenaleffects Sometendencytodecreasetotalandlow-densitylipoprotein

    cholesterol(5.8and7.3%,respec;vely)andreducesystolicbloodpressure(4.4mmHg)2

    AlthoughHMBcanbeusedforcholesterolsynthesis,itappearsthatthecholesterolsynthesisislocalized(eg,muscle)anddoesnotadverselyaffectbloodcholesterollevels

    Clinicalstudiesevalua;ngthecombina;onofHMB/Arginine/Glutamineinhealthyvolunteersandpa;entswithHIVorcancershowed4 Combina;onwassafe Improvementincertainhematologicalparameters

    1. GallagherPM,etal.MedSciSportsExerc.200032(12):2116-2119.2. NissenS,etal.JNutr.2000130(8):1937-1945.3. CroweMJ,etal.IntJSportNutrExercMetab.200313(2):184-197.4. RathmacherJA,etal.JPENJParenterEnteralNutr.200428(2):65-75.

    52

  • 7/29/2019 HMB 7 12 11

    53/55

    Addi7onalInforma7onRegardingtheSafetyofHMB

    NopublishedstudyhasreportedanyadverseeffectsofHMB However,someofthesestudiesdidnotreportadverseeventdataas

    partofthedatapresented

    ThereareverylimiteddatainhumansonHMBdosesupto6g/day

    Notreatment-relatedadverseeventswerereportedMostHMBstudiesinhumanshavebeen8weeks

    Therearesomedataoutto24weeksshowingsafetyDataonelderlyarelimited,butstudiesreviewedinthispresenta;oninbothhealthyandclinicalpopula;onshave

    notreportedadverseevents

    53

  • 7/29/2019 HMB 7 12 11

    54/55

    HMBSummary

    PrimarysourceofnaturalHMBiscatabolismoftheaminoacidleucine HMBs;mulatesmuscleproteinsynthesisandmayalso

    Increasecellmembraneintegrityviacholesterolsynthesis Decreaseindicatorsofmuscledamage(crea;nekinaselevels) Beanan;catabolicagent

    Clinicalresultsevalua;ngthebenefitsofHMBsupplementa;onaloneorwithothersupplementa;ononbodycomposi;onandstrengthhavebeen

    mixed

    Benefitsmaybereportedonceanop;malHMBdoseanddura;onthatcorrelateswithanathletessizeandtraininglevelisestablished

    ClinicalresultssuggestthatHMBimproves Aerobicperformance Condi;onsassociatedwithlossofmusclemass Woundhealingcapacity

    HMBhasbeenreportedtobesafeandwelltolerated Dataislimitedandfromshort-dura;onstudies

    54

  • 7/29/2019 HMB 7 12 11

    55/55

    2012 Abbott LaboratoriesThe EAS ACADEMY website and its content is owned by Abbott Nutrition, a division of AbbottLaboratories. All rights reserved.Any redistribution or reproduction of any part or all of the contents in any form is prohibited other than thefollowing:

    1. you may print or download to a local hard disk extracts for your personal and non-commercial useonly;

    2. you may copy the content to individual third parties for their personal use, but only if youacknowledge the website as the source of the material.

    You may not, except with our express written permission, distribute or commercially exploit the content.

    Nor may you transmit it or store it in any other website or other form of electronic retrieval system.